Precision radiotherapy delivers survival gains in inoperable lung cancer (CHISE trial)
Ten year prostate cancer trial proves optimal treatment duration (RADAR trial)
TROG Cancer Research awarded a $1.5-million grant
New CEO appointed to TROG Cancer Research
John Cleary appointed to the TROG Cancer Research Board
Broadcaster Julie McCrossin announced ast TROG's first ambassador
World first trial pioneers new standard of care for skin cancer patients
Westmead Hospital now home to revolutionary prostate cancer trial
28 Mar 2017
New approach to radiation therapy halves prostate cancer treatment time
27 Sep 2016
TROG researchers pioneer world-first new standard of care for early stage lymphoma patients
24 June 2016
'Prostate cancer survivors ten years on: New research sheds light on quality of life'
6 June 2016
'Elderly patients with glioblastoma live longer with chemoradiation using temozolomide'
'International cancer research leaders gather in Brisbane'
25 Nov 2015
'Radiotherapy trial offers hope to secondary lung cancer patient'
8 Oct 2015
'Breast cancer patient joins clinical trial to help future generations'
28 Jul 2015
'Australian-first head & neck cancer trial launches'
23 Jul 2015
'Landmark global study provides new evidence of lymph node radiation benefit in long-term breast cancer control'
25 Jun 2015
'Prostate cancer trial shows longer survival with immediate treatment'
18 May 2015
'Cancer survivor shares story of hope on International Clinical trials day'
20 Mar 2015
'International cancer research leaders gather in Newcastle'
29 Jan 2015
'Pioneering lung cancer trial could offer new hope to patients'
'New prostate treatment prevents cancer spread'
'Experts unveil latest cancer treatments'
'TROG wins NSW Premiers Award for Outstanding Cancer Research'
17 May, 2013
'International Clinical Trials Day'
Our key research areas include treatment for breast, prostate, lung, head and neck cancers.